NIH Guide: Weekly Index for July 24, 2020

Funding Opportunities

• Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
  (PAR-20-271)
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 5, 2020
• Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
  (PAR-20-276)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  National Human Genome Research Institute
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 5, 2020
• Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
  (PAR-20-277)
  National Cancer Institute
  National Institute of Dental and Craniofacial Research
  National Human Genome Research Institute
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 16, 2020
• NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
  (PAR-20-278)
  National Cancer Institute
  Application Receipt Date(s): November 6, 2020
• Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional)
  (PAR-20-281)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Institute of Environmental Health Sciences
  Office of Research on Women's Health
  Office of Disease Prevention
  Application Receipt Date(s): October 19, 2020, June 19, 2021, February 19, 2022, October 19, 2022, June 19, 2023
• Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed)
  (PAR-20-282)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Cancer Institute
  National Institute of Environmental Health Sciences
  Office of Research on Women's Health
  Office of Disease Prevention
  Application Receipt Date(s): October 19, 2020, June 19, 2021, February 19, 2022, October 19, 2022, June 19, 2023
• Limited Competition for the Continuation of the Look AHEAD (Action for Health in Diabetes) Study (U01 Clinical Trial Not Allowed)
  (RFA-AG-21-028)
  National Institute on Aging
  Application Receipt Date(s): October 30, 2020
• Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Field Epidemiology Sites (U01 - Clinical Trial Not Allowed)
  (RFA-DK-20-017)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  John E. Fogarty International Center
  Application Receipt Date(s): November 10, 2020
• Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium Renal Science Core (U01 - Clinical Trial Not Allowed)
  (RFA-DK-20-018)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): November 10, 2020
• Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Scientific Data Coordinating Center (SDCC) (U24 - Clinical Trial Not Allowed)
  (RFA-DK-20-019)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): November 10, 2020
• NIEHS Research Intensive Short Courses and Educational Opportunities (NIEHS RISE) (R25 Clinical Trial Not Allowed)
  (RFA-ES-20-015)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): November 30, 2020, November 29, 2021, November 28, 2022
• Extension of the World Trade Center Health Registry (U50)
  (RFA-OH-21-003)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): December 13, 2020
• Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Hubs (U54 Clinical Trial Optional)
  (RFA-RM-20-015)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): December 8, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Training Program (U2R Clinical Trial Optional)
  (RFA-RM-20-016)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): December 18, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Ethical, Legal, and Social Implications Research (U01 Clinical Trial Not Allowed)
  (RFA-RM-20-017)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): December 1, 2020
• Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Open Data Science Platform and Coordinating Center (U2C Clinical Trial Not Allowed)
  (RFA-RM-20-018)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): December 3, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.